Phase 1 HGBL Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

SynKIR-310 for Relapsed/Refractory B-NHL

Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma+23 more

Verismo Therapeutics36 enrolled5 locationsNCT06544265

Recruiting

Phase 1Phase 2

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Diffuse Large B-Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)Relapsed Large B-cell Lymphoma+3 more

TICAROS Co., Ltd.98 enrolled1 locationNCT07473167

Recruiting

Phase 1

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

Diffuse Large B Cell LymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3B+3 more

Shanghai Exuma Biotechnology Ltd.18 enrolled1 locationNCT06830031